BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5778831)

  • 1. Response of childhood rhabdomyosarcoma to combination chemotherapy.
    Pratt CB
    J Pediatr; 1969 May; 74(5):791-4. PubMed ID: 5778831
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy for embryonal rhabdomyosarcoma.
    Wilbur JR
    Cancer Chemother Rep; 1974; 58(2):281-4. PubMed ID: 4830502
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined chemotherapy in childhood rhabdomyosarcoma.
    Pullen DJ; Dyment PG; Hymphrey GB; Lane DM; Ragab AH
    Cancer Chemother Rep; 1975; 59(2 Pt 1):359-65. PubMed ID: 50123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.
    Pappo AS; Lyden E; Breitfeld P; Donaldson SS; Wiener E; Parham D; Crews KR; Houghton P; Meyer WH;
    J Clin Oncol; 2007 Feb; 25(4):362-9. PubMed ID: 17264331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Childhood rhabdomyosarcoma].
    Morikawa Y
    Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):431-6. PubMed ID: 16045187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A therapeutic approach to childhood pelvic rhabdomyosarcoma without pelvic exenteration.
    Ortega JA
    J Pediatr; 1979 Feb; 94(2):205-9. PubMed ID: 762607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modern treatment of vaginal embryonal rhabdomyosarcoma.
    Friedman M; Peretz BA; Nissenbaum M; Paldi E
    Obstet Gynecol Surv; 1986 Oct; 41(10):614-8. PubMed ID: 3534662
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined treatment of rhabdomyosarcoma in children].
    Armata J; Cyklis R; Legutko L; Małek T; Sitarska B; Turkiewicz A
    Pol Tyg Lek; 1981 May; 36(19):675-7. PubMed ID: 6167974
    [No Abstract]   [Full Text] [Related]  

  • 9. Extended combination therapy of childhood rhabdomyosarcoma.
    Holton CP; Chapman KE; Lackey RW; Hatch EI; Baum ES; Favara BE
    Cancer; 1973 Dec; 32(6):1310-6. PubMed ID: 4202189
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS
    Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genital rhabdomyosarcoma: current management and review of the literature.
    Bell J; Averette H; Davis J; Toledano S
    Obstet Gynecol Surv; 1986 May; 41(5):257-63. PubMed ID: 3517719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV). The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology Group.
    Raney RB; Gehan EA; Maurer HM; Newton WA; Ragab AH; Ruymann FB; Sutow WW; Tefft M
    Cancer Clin Trials; 1979; 2(1):19-28. PubMed ID: 391431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to single-dose dactinomycin in combination chemotherapy for solid tumors.
    Blatt J; Trigg ME; Pizzo PA; Glaubiger D
    Cancer Treat Rep; 1981; 65(1-2):145-7. PubMed ID: 7226164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Intergroup Rhabdomyosarcoma Study-I. A final report.
    Maurer HM; Beltangady M; Gehan EA; Crist W; Hammond D; Hays DM; Heyn R; Lawrence W; Newton W; Ortega J
    Cancer; 1988 Jan; 61(2):209-20. PubMed ID: 3275486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.
    Kojima Y; Hashimoto K; Ando M; Yonemori K; Yamamoto H; Kodaira M; Yunokawa M; Shimizu C; Tamura K; Hosono A; Makimoto A; Fujiwara Y
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):391-7. PubMed ID: 22806306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyosarcoma in childhood and adolescence.
    Maurer HM
    Curr Probl Cancer; 1978 Mar; 2(9):1-36. PubMed ID: 109248
    [No Abstract]   [Full Text] [Related]  

  • 17. [Embryonal rhabdomyosarcoma of the uvula in a 5-year-old child].
    Obrebowski A; Kaczmarek-Kanold M; Kuczkowski A
    Otolaryngol Pol; 1991; 45(5):386-90. PubMed ID: 1795928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of rhabdomyosarcoma of the prostate in children].
    Nagata Y; Hoshino H; Kinoshita H; Kawamura N; Suzuki K
    Hinyokika Kiyo; 1985 Feb; 31(2):319-26. PubMed ID: 3893070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New combination chemotherapy in refractory rhabdomyosarcoma of the prostate: a case report and review of the literature].
    Takeuchi T; Komeda H; Oguchi K; Ishihara S; Iwata H; Kanematsu M; Kuriyama M; Ban Y; Tanaka T
    Hinyokika Kiyo; 1987 Nov; 33(11):1899-905. PubMed ID: 2451411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of sarcomas-a perspective.
    Sutow WW; Maurer HM
    Semin Oncol; 1981 Jun; 8(2):207-14. PubMed ID: 6166986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.